Thursday, December 2, 2021

FDA approves Penn’s ‘glowing tumor’ imaging drug to identify ovarian cancer cells

https://ift.tt/3GayGYw

Submitted December 03, 2021 at 03:53AM by seacobs https://ift.tt/3DiJMJ3

No comments:

Post a Comment